For the study, researchers from the University of Virginia in Charlottesville tested the drug fluvoxamine’s potential to stop sepsis in mice. They found the antidepressant protected the mice from lethal septic shock by targeting a biological process that regulates inflammation.
Researchers noted additional studies are needed to determine the drug’s effectiveness in humans, but said previous safety testing could accelerate this process.
More articles on clinical leadership and infection control:
Viewpoint: How to tell patients AI is part of their care
Baptist Health South Florida’s cancer institute implements genomics platform
Antiseptic soap, mouthwash use could help reduce post-discharge MRSA by up to 44%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
